Abstract
Studies of the basic biochemical mechanisms underlying muscle damage aimed at finding agents which might reduce the amount of damage occurring in muscular dystrophy and other severe myopathies have been performed. These have suggested three types of agent which might be useful for this purpose, namely calcium antagonists, phospholipase inhibitors, and antioxidants or scavengers of reactive-free radicals. Vitamin E falls into the latter of these three categories and has been shown to reduce the amount of damage which occurs in isolated skeletal muscles following a given stress. It is suggested that, in the absence of calcium antagonists having relatively specific and effective actions on skeletal muscle or suitable inhibitors of muscle phospholipases in man, therapy with vitamin E or other antioxidants may reduce the amount of muscle damage occurring in patients with severe myopathies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bertorini, T. E., Bhattacharya, S. K., Palmieri, G. M. A., Chesney, C. M., Pifer, D. and Baker, B. Muscle calcium and magnesium content in Duchenne muscular dystrophy.Neurology 32 (1982) 1088–1092
Bicknell, F. Vitamin E in the treatment of muscular dystrophies and nervous diseases.Lancet i (1940) 10–13
Bodenstein, J. B. and Engel, A. G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567000 muscle fibres in 114 biopsies.Neurology 28 (1978) 439–446
Dawson, D. M. Efflux of enzymes from chicken muscle.Biochim. Biophys. Acta 113 (1966) 144–157
Diplock, A. T. The modulating influence of vitamin E in biological membrane unsaturated phospholipid metabolism.Acta Vit. Enzymol. 4 (1982) 303–309
Duncan, C. J. Role of intracellular calcium in promoting muscle damage: a strategy for controlling the dystrophic condition.Experientia 34 (1978) 1531–1535
Edwards, R. H. T., Jones, D. A. and Jackson, M. J. An approach to treatment trials in muscular dystrophy with particular reference to agents influencing free radial damage.Med. Biol. 62 (1984) 143–147
Fitzgerald, G. and McArdle, B. Vitamin E and B6 in the treatment of muscular dystrophy and motor neurone disease.Brain 64 (1941) 19–42
Guarnieri, C., Ferrari, R., Visioli, O., Caldarera, C. M. and Nayler, W. G. Effect of α-tocopherol on hypoxic-perfused and reoxygenated rabit heart muscle.J. Molec. Cell. Cardiol. 10 (1978) 893–906
Gutteridge, J. M. C. The effect of calcium on phospholipid peroxidation.Biochem. Biophys. Commun. 74 (1977) 529–537
Jackson, M. J., Jones, D. A. and Edwards, R. H. T. Vitamin E and skeletal muscle. InCiba Foundation Symposium Series No. 101. Biology of Vitamin E, Pitman Press, London, 1983, pp. 224–239
Jackson, M. J., Jones, D. A. and Edwards, R. H. T. Techniques for studying free radical damage in muscular dystrophy.Med. Biol. 62 (1984a) 135–138
Jackson, M. J., Jones, D. A. and Edwards, R. H. T. Experimental skeletal muscle damage: the nature of the calcium-activated degenerative processes.Eur. J. Clin. Invest. 14 (1984b) 366–374
Jain, S. K. and Shohet, S. B. Calcium potentiates the peroxidation of erythrocyte membrane lipids.Biochim. Biophys. Acta 642 (1981) 46–54
Jones, D. A., Jackson, M. J. and Edwards, R. H. T. Release of intracellular enzymes from an isolated mammalian skeletal muscle preparation.Clin. Sci. 65 (1983) 193–201
Jones, D. A., Jackson, M. J., McPhail, G. and Edwards, R. H. T. Experimental mouse muscle damage: the importance of external calcium.Clin. Sci. 66 (1984) 317–322
Maunder-Sewry, C. A., Gorodetsky, R., Yaron, R. and Dubowitz, V. Elemental analysis of skeletal muscle in Duchenne muscular dystrophy using X-ray fluorescence spectrometry.Muscle and Nerve 3 (1980) 502–508
Muller, D. P. R., Lloyd, J. K. and Wolf, O. H. Vitamin E and neurological function: abetalipoproteinaemia and other disorders of fat absorption. InCiba Foundation Symposium Series No. 101. Biology of Vitamin E, Pitman Press, London, 1983, pp. 106–121
Publicover, S. J., Duncan, C. J. and Smith, J. L. The use of A23187 to demonstrate the role of intracellular calcium in causing ultrastructural damage in mammalian muscle.J. Neuropath. Exp. Neurol. 37 (1978) 544–557
Quintanilha, A. T. and Packer, L. Vitamin E, physical exercise and tissue oxidative damage. InCiba Foundation Symposium Series No. 101. Biology of Vitmain E, Pitman Press, London, 1983, pp. 56–69
Rodemann, H. P., Waxman, L. and Goldberg, A. L. The stimulation of protein degradation in muscle by Ca2+ is mediated by prostaglandin E2 and does not require the calcium activated protease.J. Biol. Chem. 257 (1981) 8716–8723
Soybell, D., Morgan, J. and Cohen, L. Calcium augmentation of enzyme leakage from mouse skeletal muscle and its possible site of action.Res. Commun. Chem. Pathol. Pharmacol. 20 (1978) 317–329
Suarez-Kurtz, G. and Eastwood, A. B. Release of sarcoplasmic enzymes from frog skeletal muscle.Am. J. Physiol. 241 (1981) C98-C105
Tappel, L. Vitamin E as the biological lipid antioxidant.Vitamins and Hormones 20 (1962) 493–510
Walton, J. N. and Nattrass, F. J. On the classification, natural history and treatment of the myopathies.Brain 77 (1954) 169–231
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jackson, M.J., Jones, D.A. & Edwards, R.H.T. Vitamin E and muscle diseases. J Inherit Metab Dis 8 (Suppl 1), 84–87 (1985). https://doi.org/10.1007/BF01800665
Issue Date:
DOI: https://doi.org/10.1007/BF01800665